Analysts

Firm Analyst
B. Riley FBR
Madhu Kumar, Ph.D.
Bank of America Merrill Lynch
Ying Huang
BMO Capital Markets
Matthew Luchini
Chardan
Gbola Amusa, M.D., CFA
Citi
Mohit Bansal
Cowen
Ritu Baral
Evercore ISI
Joshua Schimmer, M.D.
Guggenheim Securities
Whitney Ijem
H.C. Wainwright
Debjit Chattopadhyay
Leerink
Joseph Schwartz
Mizuho
Difei Yang
Piper Jaffray
Christopher Raymond
Raymond James
Reni Benjamin, Ph.D.
Wedbush
David Nierengarten, Ph.D.
William Blair
Raju Prasad, Ph.D.

Audentes Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Audentes Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Audentes Therapeutics or its management. Audentes Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.